Eczema Ease

After leaving the pharmaceutical industry in mid-2021, Mo dedicated all his time to finding the ‘holy grail’ for atopic eczema. This included hundreds of hours of research on causes and treatments, review of guidelines from renowned institutions such as National Eczema Society, NICE, FDA, speaking with experts in dermatology and leaders in ‘alternative therapies’. 

The next step was to develop a product that would meet the needs uncovered during the research phase. As highlighted in the ‘Ideal Drug’ section above, the goal was to develop a product that would not only act fast but also moisturise and heal at the same time. In Mo’s opinion, the ideal product also needed to be as close to 100% organic as possible.

In August 2022, that search was over and Eczema Eaze was developed, and trial work began with patients who had failed on conventional therapies.